Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.38K Hold
107
0.01% 419
2026
Q1
$6.92K Hold
107
0.01% 441
2025
Q4
$7.2K Buy
+107
New +$7.2K 0.01% 433

Other funds holding HALO

Bayban's HALO Position: Q2 2026 in Review

Bayban held its Halozyme (HALO) position steady in Q2 2026 at 107 shares worth $8.38K. The position accounts for 0.01% of the portfolio, ranked #419.

Bayban first reported a position in HALO in Q4 2025 and has held it in 3 quarters since. 629 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Bayban held 107 shares of Halozyme worth $8.38K as of Q2 2026.
  • Bayban left its Halozyme share count unchanged in Q2 2026.
  • Halozyme made up 0.01% of Bayban's portfolio in Q2 2026, its #419 holding.
  • Bayban first reported a position in Halozyme in Q4 2025 and has held it in 3 quarters since.
  • 629 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Bayban's 13F filing for Q2 2026, filed 30 Jul 2026.